A traditional, protein-based COVID-19 vaccine developed by Novavax and targeting the JN.1 variant will become available next Wednesday to those eligible for free vaccination, the Centers for Disease Control (CDC) said Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Taiwan cooperation key to Indo-Pacific stability: Ex-President Tsai
10/08/2026 12:28 PM - Society
Taiwan headline news
10/08/2026 10:09 AM - Business
U.S. dollar up in Taipei trading
10/08/2026 10:09 AM - Business
Taiwan shares open lower
10/08/2026 09:08 AM - Politics
China-born spouse denied right to run for local office in Hsinchu
10/07/2026 08:59 PM